STONEPINE CAPITAL, L.P. 4
4 · Apollo Endosurgery, Inc. · Filed Aug 14, 2019
Insider Transaction Report
Form 4
STONEPINE CAPITAL, L.P.
10% Owner
Transactions
- Other
Common Stock
2019-08-12−1,000,000→ 1,580,518 total - Other
Warrant
2019-08-12+1→ 1 totalFrom: 2019-08-12→ Common Stock (1,000,000 underlying) - Purchase
6.0% Convertible Debenture due 2024
2019-08-12$2775000.00/shExercise: $3.25From: 2019-08-12Exp: 2024-08-12→ Common Stock (853,847 underlying)
Footnotes (5)
- [F1]On August 12, 2019, the Reporting Person entered into a private transaction with the Issuer pursuant to which the Reporting Person exchanged 1,000,000 shares of the issuer's Common stock, par value $0.001 per share (the "Stock"), for a pre-funded warrant (the "Warrant") to purchase 1,000,000 shares of the Stock and purchased from the Issuer a 6.0% Convertible Debenture due 2024 (the "Note").
- [F2]The exercise price of the Warrant, except for a nominal exercise price of $0.001 per share of Stock, was pre-funded on or prior to the initial exercise date by the exchange described in footnote 1.
- [F3]The Warrant terminates if the Issuer enters into certain fundamental transactions.
- [F4]Notwithstanding the number of shares reported in column 7, the Warrant may not be exercised to the extent it would cause the Reporting Person and its affiliates to beneficially own more than 9.99% of the Stock.
- [F5]Notwithstanding the number of shares reported in column 7, the Note may not be converted to the extent it would cause the Reporting Person and its affiliates to beneficially own more than 9.99% of the Stock.